Documentos de Rodríguez-Lagunas M.J. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Palabras Claves: "Pioglitazone"

Subtipo de publicación

Publisher

European Journal of Pharmaceutical Sciences(1)

International Journal of Molecular Sciences(1)

Nanomedicine: Nanotechnology, Biology, and Medicine(1)

Pharmaceutics(1)

Área temáticas

Farmacología y terapéutica(4)

Enfermedades(3)

Fisiología y materias afines(1)

Ginecología, obstetricia, pediatría, geriatría(1)

Medicina y salud(1)

Área de conocimiento

Farmacología(3)

Descubrimiento de fármacos(1)

Inflamación(1)

Año de Publicación

Origen

Palabras Claves

NANOEMULSIÓN(2)

Alzheimer's disease(1)

Atopic dermatitis(1)

Geriatric patients(1)

Mucosal permeation(1)

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases

Abstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammat

Palabras claves:

anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disorders

Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Human skin permeation studies with PPARγ agonist to improve its permeability and efficacy in inflammatory processes

Abstract: Rosacea is the most common inflammatory skin disease. It is characterized by erythema, inflammatory

Palabras claves:

inflammation, limonene, Pioglitazone, PPAR-γ, ROSÁCEA, Skin permeation

Calpena A.C., Espina M., Fábrega M.J., García M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease

Abstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily u

Palabras claves:

Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, Thiazolidinediones

Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Topical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model

Abstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show a

Palabras claves:

Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127

Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.